Background
Ultrasmall superparamagnetic particles of iron-oxide (SUPIO) particles can be used as a magnetic resonance imaging contrast (MRI) agent. Due to their dextran coating and small diameter (<30 nm), they are phagocytised by inflammatory cells [1] .
The aim of this study was to assess whether a novel acquisition/registration USPIO-MRI protocol could be used to assess myocardial cellular inflammation. Myocardial infarction and cardiac surgery was used to model myocardial inflammation [2] . An influx of macrophages can be seen in post-mortem histology, however the dynamics of in vivo patho-physiology is uncertain [3].
Methods 16 patients underwent MRI 2-4 days after ST-elevation myocardial infarction (STEMI) at baseline and 24-hours after intravenous USPIO infusion (4 mg/kg; Ferumoxytol, AMAG; n=10) or no infusion (n=6). Between 5 and 28-days following on-pump coronary artery bypass graft (CABG) surgery, 32 patients underwent the same protocol with all patients receiving USPIO.
3T-MRI (Siemens Medical) was performed to optimise USPIO sensitivity. Baseline and 24-hour multi-echo T2*weighted sequences were spatially registered to generate an R2* (1/T2*) map to assess USPIO uptake. R2* maps were spatially registered using custom software (Matlab/ Analyze) to late gadolinium enhancement (LGE) images to confirm USPIO localisation in the infarct zone. CABG R2* maps were analysed using a standard 17-segment model. 
Results
Consistent with reticuloendothelial uptake, R2* values increased in the liver & spleen following USPIO administration. In the myocardial infarct, there was a large R2* increase from 41.0±12.0 (baseline) to 155±45.0 s-1 (p<0.001) at 24h. A lower magnitude response was seen in the remote myocardium from 39±3.2 to 80±14.9 s-1 (p<0.002), consistent with myocardial inflammation that occurs post infarction [4] .
In CABG patients the R2* signal increased: 45±7s-1 to 118± 22 s-1 at 24h (p<0001). The increase in myocardial R2* values was greater than in the remote myocardium of patients with STEMI, but lower than the infarct zone itself (p<0.001 and p<0.05 respectively).
Conclusions
USPIO are taken up into inflamed myocardial tissue and can be quantitatively assessed using a multi-parameter MRI acquisition protocol with optimised spatial registration analysis based on a custom mutual information algorithm.
This represents a novel imaging technique of assessing myocardial inflammation, as well as providing a useful research tool in investigating tissue inflammation. Figure 1 Increase in R2* values in control STEMI patients (no USPIO) (blue, n=6), STEMI patients given USPIO (red, n=10) and CABG patients (green, n=32). Most significant R2* increase (and hence myocardial inflammation) observed in infarct zones, with CABG myocardial R2* increase between infarct and myocardium remote to infarction. The spatially registered regions of interests (ROI) for quantifying R2* value for STEMI and CABG patients are shown in the MRI images at the bottom of the figure.
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